Kantum Pharma

Private

Concord, New HampshireHealthcare & Life Scienceshttps://kantumpharma.com

Last Round

Series A

Jul 12, 2021

Total Funding Raised

$6.73M

Company Overview

Kantum Pharma is a biotechnology company that develops therapeutic treatments and diagnostic tests for acute kidney injury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryclinical trialsbiotechtherapeutic developmentsmall-molecule therapeuticstranslational researchdrug pipelinepreclinical researchpharmaceutical licensingbiopharmaintellectual propertyR&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kantum Pharma Comps

Public and private peers based on sector, stage, and business model.

Kantum Pharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kantum Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 12, 2021
Seed	Nov 22, 2019
Grant	Nov 15, 2017

View all Funding Rounds

Kantum Pharma Investors

Notable investors and investment history

Kantum Pharma investors
Investor	Rounds
SideCar Angels	Series A
10x Venture Partners	Series A
Millworks Fund	Series A
Broadview Ventures	Series A

View all Investors

Kantum Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kantum Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kantum Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersConcord, New Hampshire

Year Founded2016

Last FundingJul 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.